(iii) Tocilizumab and Sarilumab:
These are monoclonal antibodies which can be used to treat rheumatoid
arthritis. They can help in preventing cytokine storm which can be
happens when there is an overproduction of immune cells which attacking
self-antigens instead of defending it (Ahmed, 2020).
The Punjab government has approved the use of Actrema, a lifesaving drug
for critical patients. This can be prescribed to patients who develop
lung complications and abnormal level of interleukin 6 in the blood. The
IL-6 is an endogenous chemical which causes inflammation. These can be
useful for some patients only because there is a high risk of increase
infection level (Chaudhry, 2020a).